Deterioration in cardiometabolic risk markers in obese women during depot medroxyprogesterone acetate use

Contraception

Volumn 85, Issue 1, 2012, Pages 36-41

  Segall Gutierrez, Penina ^a   Xiang, Anny H ^a,b   Watanabe, Richard M ^a   Trigo, Enrique ^a   Stanczyk, Frank Z ^a   Liu, Xinwen ^a   Jurow, Ronna ^a   Buchanan, Thomas A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

Beta cell function; Body mass index; Cardiometabolic; Contraception; Depot medroxyprogesterone acetate; Insulin resistance; Obesity

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; METABOLISM; MORPHOMETRICS; OBESITY; PANCREAS ISLET BETA CELL; PREGNANCY; PROSPECTIVE STUDY; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; INSULIN RESISTANCE; MEDROXYPROGESTERONE ACETATE; OBESITY; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 82755198052     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2011.04.016     Document Type: Article

References (30)

1. K.M. Flegal, M.D. Carroll, C.L. Ogden, and C.L. Johnson Prevalence and trends in obesity among US adults, 1999-2000 JAMA 288 2002 1723 1727
2. I. Guelinckx, R. Devlieger, K. Beckers, and G. Vansant Maternal obesity: pregnancy complications, gestational weight gain and nutrition Obesity Rev 9 2008 140 150 (Pubitemid 351197441)
3. S.M. Grundy, J.I. Cleeman, and S.R. Daniels Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement Circulation 112 2005 2735 2752 (Pubitemid 41532612)
4. P. Arroyo, H. Avila-Rosas, V. Fernandez, E. Casanueva, and D. Galvan Parity and the prevalence of overweight Int J Gynaecol Obstet 48 1995 269 272
5. A. Ortiz, M. Hiroi, F.Z. Stanzyck, U. Goebelsmann, and D.R. Mishell Serum medroxyprogesterone acetate (MPA) contraception and ovarian function following intramuscular injection of depo-MPA J Clinical Endocrinol Metab 44 1977 32 38 (Pubitemid 8030779)
6. J. Jain, C. Dutton, A. Nicosia, C. Wajszczuk, F.R. Bode, and D.R. Mishell Pharmacokinetics, ovulation suppression, and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera Contraception 70 2004 11 18 (Pubitemid 38781973)
7. P. Segall-Gutierrez, D. Taylor, X. Liu, F. Stanzyck, S. Azen, and D.R. Mishell Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously Contraception 81 2010 487 495
8. Centers for Disease Control and Prevention U.S. medical eligibility criteria for contraceptive use, 2010 MMWR Early Release 59 2010 1 88
9. K. Amatayukul The effects of Depo-Provera on carbohydrate, lipids and vitamin metabolism J Steroid Biochem 11 1979 475 481
10. K. Dhali, M. Kumar, G.K. Rastogi, and P.K. Devi Short term effects of norethisterone oenanthate and medroxyprogesterone acetate on glucose, insulin, growth hormone, and lipids Fertil Steril 28 1977 156 158 (Pubitemid 8047694)
11. M. Tankeyoon, N. Dusitsin, V. Poshyachinda, and U. Larsson-Cohn A study of glucose tolerance, serum transaminase and lipids in women using depot-medroxyprogesterone acetate and a combination-type oral contraceptive Contraception 14 1976 199 214
12. T. Bagis, A. Gokcel, H.B. Zeyneloglu, E. Tarim, E.B. Kilicdag, and B. Haydardedeoglu The effects of short- term medroxyprogesterone acetate and micronized progesterone on glucose metabolism and lipid profiles in patients with polycystic ovary syndrome: a prospective randomized study J Clin Endocrinol Metab 87 2002 4536 4540 (Pubitemid 35247037)
13. S. Graff-Iverson, and S. Tonstad Use of progesterone-only contraceptive medications and lipid parameters in women age 4042 years: results from a population-based cross-sectional Norwegian survey Contraception 66 2002 7 13 (Pubitemid 34880199)
14. P. Virutamasen, C. Wongsrichanalai, P. Tangkeo, Y. Nitichai, and D. Rienprayoon Metabolic effects of depot-medroxyprogesterone acetate in long-term users: a cross-sectional study Int J Gynaecol Obstet 24 1986 291 296 (Pubitemid 16077410)
15. K. Amatayukul, B. Sivassomboon, and R. Singkamani Effects of medroxyprogesterone acetate on serum lipids, protein, glucose tolerance and liver function in Thai women Contraception 21 1980 283 297 (Pubitemid 10110391)
16. K. Fahmy, M. Abdel-Razik, and M. Shaaraway Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile Contraception 44 1991 419 430
17. D.F. Liew, C.S. Ng, Y.M. Yong, and S.S. Ratnam Long-term effects of Depo-Provera on carbohydrate and lipid metabolism Contraception 31 1985 51 64 (Pubitemid 15058103)
18. C. Kim, K.W. Seidel, E.A. Begier, and Y.S. Kwok Diabetes and depot medroxyprogesterone contraception in Navajo women Arch Internal Med 161 2001 1766 1771 (Pubitemid 32679552)
19. A.H. Xiang, M. Kawakubo, S.L. Kjos, and T.A. Buchanan Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus Diab Care 29 2006 613 617 (Pubitemid 44121124)
20. S.L. Kjos, R.K. Peters, A. Xiang, D. Thomas, U. Schaefer, and T.A. Buchanan Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus JAMA 280 1998 533 588
21. M.H. Black, T.E. Fingerlin, H. Allayee, W. Zhang, A.H. Xiang, and E. Trigo Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans Diabetes 57 2008 1048 1056
22. G. Pacini, and R.N. Bergman MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test Comput Methods Programs Biomed 23 1986 113 122 (Pubitemid 16027716)
23. R.N. Bergman, L.S. Phillips, and C. Cobelli Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose J Clin Invest 68 1981 1456 1467 (Pubitemid 12194400)
24. R.N. Bergman Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal model approach Diabetes 38 1989 1512 1527 (Pubitemid 20006675)
25. H.S. Kahn, K.M. Curtis, and P.A. Marchbanks Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk Diab Care 26 2003 216 225 (Pubitemid 36929020)
26. A.B. Berenson, P. van den Berg, K.J. Williams, and M. Rahman Effect of injectable and oral contraceptives on glucose and insulin levels Obstet Gynecol 117 2011 41 47
27. A.H. Xiang, M. Kawakubo, T.A. Buchanan, and S.L. Kjos A longitudinal study of lipids and blood pressure in relation to method of contraception in Latino women with prior gestational diabetes mellitus Diab Care 30 2007 1952 1958 (Pubitemid 47219399)
28. S. Sidney, D.B. Pettiti, G.A. Soff, D.L. Cundiff, K.K. Tolan, and C.P. Queensberry Jr Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives Contraception 70 2004 3 10 (Pubitemid 38781972)
29. American College of Obstetricians and Gynecologists Use of hormonal contraception in women with coexisting medical conditions. ACOG Practice Bulletin #73 Obstet Gynecol 107 2006 1453 1472
30. P. Segall-Gutierrez, A. Xiang, and R. Watanabe Changes in insulin sensitivity and β-cell responsiveness in obese women using depomedroxyprogesterone acetate Contraception 80 2009 216 217